| Outcome | Probability | Yes Bid | Yes Ask | 24h Change | Volume | |
|---|---|---|---|---|---|---|
| Before Jan 4, 2027 | 0% | 0¢ | 0¢ | — | $0 | Trade → |
This market asks whether a legislative bill that would curb pharmaceutical monopolies will be enacted as law. The outcome matters for drug pricing, innovation incentives, and market competition in the pharmaceutical sector.
Bills targeting pharmaceutical monopolies typically aim to limit practices like patent extensions, pay-for-delay settlements, or other tactics that delay generic and biosimilar competition. Historically, proposals that change intellectual property or antitrust rules face sustained lobbying from industry, scrutiny from regulators, and partisan negotiation in legislatures. The bill’s prospects will depend on the legislative calendar, coalition building, and reactions from stakeholders including manufacturers, insurers, and patient advocacy groups.
Market prices reflect participants’ aggregated expectations about whether the bill will complete the legal steps required to become law. Prices update as new information emerges (committee votes, floor actions, executive signals, amendments, or legal challenges).
For this market, 'become law' means the bill completes the formal legal enactment process in the applicable jurisdiction (passage by the required legislative body or bodies and any required executive approval), so it is legally enacted and in force.
Monitor committee referrals and votes, procedural milestones (scheduling for floor debate), passage votes in each chamber required by that legislature, and any reconciliation processes if separate chambers pass different versions.
Key players include chamber leaders and swing votes on relevant committees, executive branch officials who can sign or veto, industry trade groups and major manufacturers, patient advocacy organizations, and influential committee staff and regulators.
Significant amendments can broaden or narrow support: compromises may increase the chance of passage by winning over opponents, while changes that remove core provisions can generate new opposition. Markets will reprice as the text and support change.
This market resolves based on whether the bill becomes law through the legislative/executive process. Post-enactment court challenges do not negate that it became law, though they can affect the bill’s implementation and future legal status.